User menu

Pneumococcal sepsis in patients with systemic lupus erythematosus.

Bibliographic reference Naveau, C. ; Houssiau, Frédéric. Pneumococcal sepsis in patients with systemic lupus erythematosus.. In: Lupus, Vol. 14, no. 11, p. 903-6 (2005)
Permanent URL http://hdl.handle.net/2078.1/10414
  1. Cervera Ricard, Khamashta Munther A., Font Josep, Sebastiani Gian Domenico, Gil Antonio, Lavilla Paz, Aydintug A. Olcay, Jedryka-Góral Anna, Ramón Enrique de, Fernández-Nebro Antonio, Galeazzi Mauro, Haga Hans-Jacob, Mathieu Alessandro, Houssiau Frédéric, Ruiz-Irastorza Guillermo, Ingelmo Miguel, Hughes Graham R.V., Morbidity and Mortality in Systemic Lupus Erythematosus During a 5-Year Period: A Multicenter Prospective Study of 1,000 Patients : , 10.1097/00005792-199905000-00003
  2. Cervera Ricard, Khamashta Munther A., Font Josep, Sebastiani Gian Domenico, Gil Antonio, Lavilla Paz, Mejía Juan Carlos, Aydintug A. Olcay, Chwalinska-Sadowska Hanna, de Ramón Enrique, Fernández-Nebro Antonio, Galeazzi Mauro, Valen Merete, Mathieu Alessandro, Houssiau Frédéric, Caro Natividad, Alba Paula, Ramos-Casals Manuel, Ingelmo Miguel, Hughes Graham R.V., Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period : A Comparison of Early and Late Manifestations in a Cohort of 1,000 Patients, 10.1097/01.md.0000091181.93122.55
  3. Kang Insoo, Park Sung Hwan, Infectious complications in SLE after immunosuppressive therapies : , 10.1097/00002281-200309000-00002
  4. Gladman D D, Hussain F, Iban D, Urowitz M B, The nature and outcome of infection in systemic lupus erythematosus, 10.1191/0961203302lu170oa
  5. Dillon AM, J Rheumatol, 7, 196 (1980)
  6. Garred P, Arthritis Rheum, 42, 2145 (1999)
  7. Lauwerys Bernard R., Garot Nathalie, Renauld Jean‐Christophe, Houssiau Frédéric A., Interleukin‐10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients, 10.1002/1529-0131(200009)43:9<1976::aid-anr8>3.0.co;2-v
  8. Van Der Straeten C, J Rheumatol, 14, 1177 (1987)
  9. Petros D, West S, Overwhelming pneumococcal bacteraemia in systemic lupus erythematosus., 10.1136/ard.48.4.333
  10. Hill Michael D., Karsh Jacob, Invasive soft tissue infections withStreptococcls Pneumoniae in patients with systemic lupus erythematosus. Case report and review of the literatur, 10.1002/art.1780400924
  11. Mackenzie A R, Laing R B S, MacDonald A G, Smith C C, Pneumococcal septicaemia in a patient with systemic lupus erythematosus, 10.1136/ard.56.7.403
  12. Ginzler Ellen, Diamond Herbert, Kaplan David, Weiner Max, Schlesinger Michael, Seleznick Mitchel, Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus, 10.1002/art.1780210107
  13. Austrian R, Trans Assoc Am Physicians, 89, 184 (1976)
  14. Shapiro Eugene D., Berg Anne T., Austrian Robert, Schroeder Donna, Parcells Valerie, Margolis Amy, Adair Russell K., Clemens John D., The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide Vaccine, 10.1056/nejm199111213252101
  15. Butler Jay C., Pneumococcal Polysaccharide Vaccine Efficacy : An Evaluation of Current Recommendations, 10.1001/jama.1993.03510150060030
  16. Jackson Lisa A., Neuzil Kathleen M., Yu Onchee, Benson Patti, Barlow William E., Adams Annette L., Hanson Christi A., Mahoney Lisa D., Shay David K., Thompson William W., Effectiveness of Pneumococcal Polysaccharide Vaccine in Older Adults, 10.1056/nejmoa022678
  17. Dear K, Cochrane Database Syst Rev, 4 (2003)
  18. Klippel John H, Karsh Jacob, Stahl Neil I, Decker John L, Steinberg Alfred D, Schiffman Gerald, A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus, 10.1002/art.1780221201
  19. Jarrett Mark P., Schiffman Gerald, Barland Peter, Grayzel Arthur I., Impaired response to pneumococcal vaccine in systemic lupus erythematosus, 10.1002/art.1780231110
  20. Lipnick RN, J Rheumatol, 12, 1118 (1985)
  21. Tarján P., Sipka S., Maródi L., Nemes E., Lakos G., Gyimesi E., Kiss E., Ujj Gy., Szegedi Gy., No short-term immunological effects of Pneumococcus vaccination in patients with systemic lupus erythematosus, 10.1080/030097402320318396
  22. Whitney Cynthia G., Farley Monica M., Hadler James, Harrison Lee H., Bennett Nancy M., Lynfield Ruth, Reingold Arthur, Cieslak Paul R., Pilishvili Tamara, Jackson Delois, Facklam Richard R., Jorgensen James H., Schuchat Anne, Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine, 10.1056/nejmoa022823
  23. Reinert R. R., Reinert S., van der Linden M., Cil M. Y., Al-Lahham A., Appelbaum P., Antimicrobial Susceptibility of Streptococcus pneumoniae in Eight European Countries from 2001 to 2003, 10.1128/aac.49.7.2903-2913.2005
  24. Vanhoof R., Carpentier M., Cartuyvels R., Damée S., Fagnart O., Garrino M.-G., Glupczynski Y., Gordts B., Govaerts D., Magerman K., Mans I., Surmont I., Van Bossuyt E., Van De Vyvere M., Van Landuyt H., Van Nimmen L., Van Noyen R., SURVEILLANCE OF ANTIBIOTIC RESISTANCE IN CLINICAL ISOLATES OFSTREPTOCOCCUS PNEUMONIAECOLLECTED IN BELGIUM DURING WINTER 2000-2001, 10.1179/acb.2003.58.2.007